Upstate Active Clinical Trials
Study Title:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL GROUP, MULTICENTER TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES
What is the purpose of the study? (in Layman's terms, please describe the study)To evaluate the efficacy of CVL-865 as adjunctive therapy compared with placebo in subjects with focal onset seizures.
Upstate Institutional Review Board (IRB) Number:1539947
Patient Age Group:Adults
Principal Investigator:Robert L Beach
What is involved if I participate?
- How long is the study?
Approximately 4 months.
Who can I contact for more information?
Name: Marielle N Posmik